MarginsXMarginsX
Home › Markets › Health Care › MCK

McKesson Corporation (MCK)

MCK trades on NYSE in Health Care, Other Pharmaceuticals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1105.04
+0.20% on the day
Market cap
$127.6B
Large cap
Revenue · 2025
$403.4B
+12.4% on 2024
Net income · 2025
$4.8B
1.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/927653/000092765326000069/0000927653-26-000069-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-31.

Profile

FieldValue
TickerMCK on NYSE
SectorHealth Care
IndustryOther Pharmaceuticals
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000927653
SEC industry codeWholesale-Drugs, Proprietaries & Druggists' Sundries
Incorporated inDE

Financials · 2025

LineValue
Revenue$403.4B
Net income$4.8B
Operating income$6.2B
Net margin1.2%
Operating margin1.5%
Revenue growth+12.4%
Cash$4.0B
Total assets$82.3B
P/E (computed)26.8×
P/S (computed)0.3×

Warning signs

Cash runway
Cash-flow positive
$6.5B cash at September 30, 2026
Share count, 1 year
-6.5%
2025-10-31 to 2026-10-30 · -13.2% over 3 years
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
-$28.3M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$6.5B cash; operating cash flow $1.9B a quarter.Report 2026-09-30
Shares outstanding115,456,664 (2026-10-30); 123,426,650 a year earlier; 133,062,485 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-02-05
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2026-10-30
AuditorDeloitte & Touche LLP, Dallas, Texas, United StatesPCAOB Form AP 2026-05-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $28.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2027
2026-09-30
$111.0B$1.2B$3.1B$6.5B$9.2B$418.8B10-Q 2026-11-04
Q1 2027
2026-06-30
$105.4B$614.0M-$220.0M$5.2B$9.7B$411.0B10-Q 2026-08-05
Q4 2026
2026-03-31
$96.3B$1.7B$3.4B$4.0B$6.5B$403.4B10-K 2026-05-08
Q3 2026
2025-12-31
$106.2B$1.2B$1.2B$3.0B$6.6B$398.0B10-Q 2026-02-04
Q2 2026
2025-09-30
$103.2B$1.1B$2.4B$4.0B$7.8B$387.1B10-Q 2026-11-04
Q1 2026
2025-06-30
$97.8B$784.0M-$918.0M$2.4B$7.8B$377.6B10-Q 2026-08-05
Q4 2025
2025-03-31
$90.8B$1.3B$7.7B$5.7B$5.7B$359.1B10-K 2026-05-08
Q3 2025
2024-12-31
$95.3B$879.0M-$2.4B$1.1B$8.0B$344.6B10-Q 2026-02-04

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-02-05
Latest annual report10-K2026-05-08
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-06-30

Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.0%
1 month+14.7%
3 months+28.7%
Year to date+34.4%
1 year+30.3%
From 52-week high0.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Other Pharmaceuticals

TickerCompanyPriceDayMarket cap
CORCencora Inc.$356.94-0.58%$68.1B
CAHCardinal Health Inc.$283.85+0.98%$65.6B
HLFHerbalife Ltd. Common Shares$16.15+1.19%$1.7B
COSMCosmos Health Inc.$2.49-23.15%$250.6M
NUSNu Skin Enterprises Inc.$3.93-2.48%$191.3M
ZSTKZeroStack Corp.$2.80-1.75%$61.1M
ESYNEnerSyn Global Inc.$1.250.00%$37.2M
HKPDCellyan Biotechnology Co. Ltd$1.61-0.62%$4.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier